Phenylbutyrate Response as a Biomarker for Alpha-synuclein Clearance From the Brain

NCT02046434 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Glycerol Phenylbutyrate

Sponsor

University of Colorado, Denver